ITTO20040343A1 - Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo - Google Patents
Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivoInfo
- Publication number
- ITTO20040343A1 ITTO20040343A1 IT000343A ITTO20040343A ITTO20040343A1 IT TO20040343 A1 ITTO20040343 A1 IT TO20040343A1 IT 000343 A IT000343 A IT 000343A IT TO20040343 A ITTO20040343 A IT TO20040343A IT TO20040343 A1 ITTO20040343 A1 IT TO20040343A1
- Authority
- IT
- Italy
- Prior art keywords
- neboglamine
- neuropsychotic
- neuroprotective
- dimethylcyclohexyl
- racemate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000343A ITTO20040343A1 (it) | 2004-05-24 | 2004-05-24 | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
DE602005020618T DE602005020618D1 (de) | 2004-05-24 | 2005-05-23 | Verwendung von neboglamine zur behandlung von schizophrenie |
CA2567397A CA2567397C (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective |
JP2007513918A JP4898666B2 (ja) | 2004-05-24 | 2005-05-23 | 抗精神病薬および神経保護薬としてのネボグラミン(neboglamine)(CR2249)の使用 |
US11/569,545 US7737180B2 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective |
AT05747915T ATE464042T1 (de) | 2004-05-24 | 2005-05-23 | Verwendung von neboglamine zur behandlung von schizophrenie |
PT05747915T PT1755583E (pt) | 2004-05-24 | 2005-05-23 | Uso de neboglamina (cr 2249) como um antipsicótico e neuroprotector |
PL05747915T PL1755583T3 (pl) | 2004-05-24 | 2005-05-23 | Zastosowanie neboglaminy do leczenia schizofrenii |
DK05747915.6T DK1755583T3 (da) | 2004-05-24 | 2005-05-23 | Anvendelse af neboglamin til behandling af skizofreni |
EP05747915A EP1755583B1 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine for the treatment of schizophrenia |
ES05747915T ES2340399T3 (es) | 2004-05-24 | 2005-05-23 | Uso de neboglamina para el tratamiento de la esquizofrenia. |
PCT/EP2005/052340 WO2005115373A1 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective |
AU2005247114A AU2005247114B2 (en) | 2004-05-24 | 2005-05-23 | Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000343A ITTO20040343A1 (it) | 2004-05-24 | 2004-05-24 | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
Publications (1)
Publication Number | Publication Date |
---|---|
ITTO20040343A1 true ITTO20040343A1 (it) | 2004-08-24 |
Family
ID=34968609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000343A ITTO20040343A1 (it) | 2004-05-24 | 2004-05-24 | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
Country Status (13)
Country | Link |
---|---|
US (1) | US7737180B2 (it) |
EP (1) | EP1755583B1 (it) |
JP (1) | JP4898666B2 (it) |
AT (1) | ATE464042T1 (it) |
AU (1) | AU2005247114B2 (it) |
CA (1) | CA2567397C (it) |
DE (1) | DE602005020618D1 (it) |
DK (1) | DK1755583T3 (it) |
ES (1) | ES2340399T3 (it) |
IT (1) | ITTO20040343A1 (it) |
PL (1) | PL1755583T3 (it) |
PT (1) | PT1755583E (it) |
WO (1) | WO2005115373A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20050691A1 (it) * | 2005-10-04 | 2007-04-05 | Rottapharm Spa | Uso di neboglamine nella terapia delle tossicodipendenze |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1931927A1 (de) * | 1968-07-06 | 1970-01-15 | Yamanouchi Pharma Co Ltd | Neue Cyclohexylaminderivate |
IT1264765B1 (it) | 1993-03-10 | 1996-10-04 | Rotta Research Lab | Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la |
AR037460A1 (es) | 2001-11-30 | 2004-11-10 | Smithkline Beecham Plc | Compuesto de hidroxietileno, composicion farmaceutica que lo comprende, uso del mismo para la fabricacion de un medicamento y procedimiento para su preparacion |
-
2004
- 2004-05-24 IT IT000343A patent/ITTO20040343A1/it unknown
-
2005
- 2005-05-23 DK DK05747915.6T patent/DK1755583T3/da active
- 2005-05-23 AU AU2005247114A patent/AU2005247114B2/en not_active Ceased
- 2005-05-23 WO PCT/EP2005/052340 patent/WO2005115373A1/en active Application Filing
- 2005-05-23 JP JP2007513918A patent/JP4898666B2/ja not_active Expired - Fee Related
- 2005-05-23 PL PL05747915T patent/PL1755583T3/pl unknown
- 2005-05-23 ES ES05747915T patent/ES2340399T3/es active Active
- 2005-05-23 CA CA2567397A patent/CA2567397C/en not_active Expired - Fee Related
- 2005-05-23 AT AT05747915T patent/ATE464042T1/de active
- 2005-05-23 EP EP05747915A patent/EP1755583B1/en not_active Not-in-force
- 2005-05-23 DE DE602005020618T patent/DE602005020618D1/de active Active
- 2005-05-23 US US11/569,545 patent/US7737180B2/en not_active Expired - Fee Related
- 2005-05-23 PT PT05747915T patent/PT1755583E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
PL1755583T3 (pl) | 2010-09-30 |
DE602005020618D1 (de) | 2010-05-27 |
WO2005115373A1 (en) | 2005-12-08 |
EP1755583B1 (en) | 2010-04-14 |
AU2005247114A1 (en) | 2005-12-08 |
ATE464042T1 (de) | 2010-04-15 |
PT1755583E (pt) | 2010-05-07 |
AU2005247114B2 (en) | 2010-06-03 |
CA2567397A1 (en) | 2005-12-08 |
JP4898666B2 (ja) | 2012-03-21 |
US20070249715A1 (en) | 2007-10-25 |
US7737180B2 (en) | 2010-06-15 |
ES2340399T3 (es) | 2010-06-02 |
DK1755583T3 (da) | 2010-07-19 |
EP1755583A1 (en) | 2007-02-28 |
CA2567397C (en) | 2013-03-12 |
JP2008500309A (ja) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
HK1084941A1 (en) | Compounds and their use | |
BRPI0416628A (pt) | uso de compostos orgánicos | |
CY1110745T1 (el) | Παραγωγα πυρρολιδονης ως αναστολεις μαοβ | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
DE602005023185D1 (de) | Prodrugs mit neuen biospaltbaren verbindern | |
EA200400481A1 (ru) | Применение флибансерина для лечения половых расстройств | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
BRPI0407662A (pt) | derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas | |
NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
UA83691C2 (ru) | Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона | |
DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
BRPI0417714A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
ITTO20040343A1 (it) | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo | |
TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |